Schneider K, Allen S, ORourke A, Reid M, Conrad M, Hughes P
Drug Alcohol Depend Rep. 2024; 13:100285.
PMID: 39498371
PMC: 11532271.
DOI: 10.1016/j.dadr.2024.100285.
Roth A, Ward K, Hensel D, Elliott L, Bennett A
PLoS One. 2024; 19(7):e0307151.
PMID: 39024257
PMC: 11257247.
DOI: 10.1371/journal.pone.0307151.
Erinoso O, Daugherty R, Kirk M, Harding R, Etchart H, Reyes A
Int J Drug Policy. 2024; 128:104456.
PMID: 38761461
PMC: 11590564.
DOI: 10.1016/j.drugpo.2024.104456.
Young A, Havens J, Cooper H, Fallin-Bennett A, Fanucchi L, Freeman P
BMJ Open. 2024; 14(3):e083983.
PMID: 38431295
PMC: 10910671.
DOI: 10.1136/bmjopen-2024-083983.
Walker J, Kirtadze I, Tabatadze M, Vickerman P, Otiashvili D
Harm Reduct J. 2023; 20(1):103.
PMID: 37533020
PMC: 10394772.
DOI: 10.1186/s12954-023-00829-3.
A scoping review of implementation considerations for harm reduction vending machines.
Russell E, Johnson J, Kosinski Z, Kaplan C, Barnes N, Allen S
Harm Reduct J. 2023; 20(1):33.
PMID: 36927354
PMC: 10018614.
DOI: 10.1186/s12954-023-00765-2.
"There's absolutely no downside to this, I mean, except community opposition:" A qualitative study of the acceptability of vending machines for harm reduction.
Stewart R, Cardamone N, Loscalzo E, French R, Lovelace C, Mowenn W
Harm Reduct J. 2023; 20(1):25.
PMID: 36855064
PMC: 9971672.
DOI: 10.1186/s12954-023-00747-4.
Qualitative exploration of public health vending machines in young adults who misuse opioids: A promising strategy to increase naloxone access in a high risk underserved population.
Wagner N, Kempe A, Barnard J, Rinehart D, Havranek E, Glasgow R
Drug Alcohol Depend Rep. 2023; 5.
PMID: 36687307
PMC: 9851265.
DOI: 10.1016/j.dadr.2022.100094.
Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
Arendt D
J Am Pharm Assoc (2003). 2022; 63(1):309-316.
PMID: 36549931
PMC: 9870941.
DOI: 10.1016/j.japh.2022.10.027.
Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
Allen S, ORourke A, Johnson J, Cheatom C, Zhang Y, Delise B
Ann Med. 2022; 54(1):2692-2700.
PMID: 36168975
PMC: 9542801.
DOI: 10.1080/07853890.2022.2121418.
A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
Batty E, Ibragimov U, Fadanelli M, Gross S, Cooper K, Klein E
J Rural Health. 2022; 39(2):328-337.
PMID: 36117151
PMC: 10484119.
DOI: 10.1111/jrh.12715.
Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia.
OKeefe D, Livingston M, Cossar R, Kerr P, Jacka D, Dietze P
Harm Reduct J. 2022; 19(1):101.
PMID: 36071500
PMC: 9449958.
DOI: 10.1186/s12954-022-00683-9.
Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.
Coupland H, Henderson C, Pritchard-Jones J, Kao S, Sheils S, Nagy R
Harm Reduct J. 2022; 19(1):56.
PMID: 35643528
PMC: 9148492.
DOI: 10.1186/s12954-022-00640-6.
Emergency department care for patients who use opioids during the COVID-19 pandemic.
Weicker S, Speed K, Hyshka E, Mrochuk M, Kosteniuk B, Dong K
CJEM. 2021; 24(2):123-125.
PMID: 34817838
PMC: 8611999.
DOI: 10.1007/s43678-021-00229-1.
Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.
Broz D, Carnes N, Chapin-Bardales J, Des Jarlais D, Handanagic S, Jones C
Am J Prev Med. 2021; 61(5 Suppl 1):S118-S129.
PMID: 34686281
PMC: 11334402.
DOI: 10.1016/j.amepre.2021.05.044.
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
Galarneau L, Hilburt J, ONeill Z, Buxton J, Scheuermeyer F, Dong K
PLoS One. 2021; 16(7):e0255396.
PMID: 34324589
PMC: 8320992.
DOI: 10.1371/journal.pone.0255396.
Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.
Lancaster K, Cooper H, Browning C, Malvestutto C, Bridges J, Young A
Subst Use Misuse. 2020; 55(14):2268-2277.
PMID: 32748730
PMC: 7584727.
DOI: 10.1080/10826084.2020.1800741.
Pharmacy on-site overdose protocols and prevention of overdose.
Green T, Soipe A, Baloy B, Burstein D, Xuan Z, Tapper A
Subst Abus. 2020; 43(1):64-68.
PMID: 32186478
PMC: 10937094.
DOI: 10.1080/08897077.2020.1736236.
Application of data mining techniques and logistic regression to model drug use transition to injection: a case study in drug use treatment centers in Kermanshah Province, Iran.
Najafi-Ghobadi S, Najafi-Ghobadi K, Tapak L, Aghaei A
Subst Abuse Treat Prev Policy. 2019; 14(1):55.
PMID: 31831013
PMC: 6909482.
DOI: 10.1186/s13011-019-0242-1.
Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
OKeefe D, Wilkinson A, Aitken C, Dietze P
PLoS One. 2018; 13(12):e0209280.
PMID: 30550588
PMC: 6294429.
DOI: 10.1371/journal.pone.0209280.